Pfizer's Pricing: Undervalued by 54.9%?

Pfizer's share price recently closed at $25.52, with returns of 1.5% over 7 days and 2.7% over 1 year. Recent attention has focused on the business's position after the initial Covid vaccine period and its long-term portfolio and pipeline. Using a Discounted Cash Flow (DCF) analysis, Pfizer's intrinsic value is estimated at $56.53 per share, indicating an intrinsic discount of 54.9% compared to the recent share price. This suggests that Pfizer is undervalued by 54.9%.